{
    "clinical_study": {
        "@rank": "5066", 
        "brief_summary": {
            "textblock": "To determine the safety and effectiveness of a combination chemotherapy-radiation-zidovudine\n      (AZT) treatment for patients with peripheral lymphoma.\n\n      Other chemotherapies have been tried in patients with AIDS related lymphomas, but the\n      results have not been satisfactory. This study will show whether the combination of\n      chemotherapy, radiation, and AZT is more effective and less toxic than previously used\n      treatments."
        }, 
        "brief_title": "Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members", 
        "completion_date": {
            "#text": "March 1990", 
            "@type": "Actual"
        }, 
        "condition": [
            "Lymphoma, Non-Hodgkin", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Lymphoma", 
                "Lymphoma, Non-Hodgkin"
            ]
        }, 
        "detailed_description": {
            "textblock": "Other chemotherapies have been tried in patients with AIDS related lymphomas, but the\n      results have not been satisfactory. This study will show whether the combination of\n      chemotherapy, radiation, and AZT is more effective and less toxic than previously used\n      treatments.\n\n      All patients will receive combination chemotherapy and AZT. The combination chemotherapy\n      will be repeated every 3 to 4 weeks for a maximum total of 6 cycles. Each cycle will consist\n      of doxorubicin, bleomycin, cyclophosphamide, and vincristine on day 1, dexamethasone on days\n      1-5, and methotrexate on day 15. Patients with meningeal or bone marrow disease will receive\n      radiation and intrathecal cytarabine (ARA-C) while those without will receive ARA-C without\n      radiation. Patients with documented lymphomas in the central nervous system at initial\n      workup will start radiation as soon as possible and intrathecal ARA-C (t.i.w. until\n      cerebrospinal fluid is clear then every month for 1 year); patients with normal lumbar\n      puncture, brain scan, and bone marrow at first diagnosis will begin radiation on day 1 of\n      cycle 3 of chemotherapy. Lumbar punctures for evaluation will be done four times during the\n      first cycle, on days 1, 8, 21, and 28. AZT will be administered every 4 hours, 7 days a\n      week, beginning at the completion of combined chemotherapy, once the patient has achieved a\n      complete remission of the lymphoma, and continuing for 1 year."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Ibuprofen.\n\n          -  Standard antiemetic agents.\n\n          -  Ganciclovir therapy for sight- or life-threatening Cytomegalovirus infection.\n\n          -  Zidovudine and methotrexate may be resumed during ganciclovir maintenance phase.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        The following patients will be excluded from the study:\n\n          -  Patients with recurrent infection that may interfere with the planned protocol.\n\n          -  Patients with a second active tumor other than nonmelanomatous skin cancer or\n             Kaposi's sarcoma.\n\n          -  Patients with stage IE primary central nervous system lymphoma.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Corticosteroids.\n\n          -  Aspirin.\n\n          -  Acetaminophen.\n\n          -  Nonsteroidal anti-inflammatory drugs, except ibuprofen.\n\n          -  Chemotherapy for infection associated with neutropenia.\n\n          -  Zidovudine (AZT) for infection associated with neutropenia.\n\n          -  Investigational therapies, except ganciclovir therapy for sight- or life-threatening\n             cytomegalovirus infection.\n\n          -  AZT and methotrexate will be suspended during induction therapy with ganciclovir.\n\n        The following patients will be excluded from the study:\n\n          -  Patients with recurrent infection that may interfere with  the planned protocol.\n\n          -  Patients with a second active tumor other than nonmelanomatous skin cancer or\n             Kaposi's sarcoma.\n\n          -  Patients with stage IE primary central nervous system lymphoma.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Zidovudine (AZT).\n\n          -  Excluded within 2 weeks of study entry:\n\n          -  Immunomodulating agents.\n\n          -  Antiretroviral therapy prior to diagnosis of lymphoma.\n\n        Patients must demonstrate the following clinical and laboratory findings:\n\n          -  Any stage of the disease, including stage I.\n\n          -  Newly diagnosed, previously untreated high-grade lymphoma.\n\n          -  Presence of measurable tumor parameter(s).\n\n          -  Adequate hepatic, renal, and bone marrow function."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": "45", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000703", 
            "org_study_id": "ACTG 008", 
            "secondary_id": "10984"
        }, 
        "intervention": [
            {
                "intervention_name": "Bleomycin sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Vincristine sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Allopurinol", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Methotrexate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Cytarabine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Leucovorin calcium", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Dexamethasone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Allopurinol", 
                "BB 1101", 
                "Methotrexate", 
                "Zidovudine", 
                "Cytarabine", 
                "Cyclophosphamide", 
                "Antineoplastic Agents", 
                "Bleomycin", 
                "Dexamethasone", 
                "Doxorubicin", 
                "Vincristine", 
                "Dexamethasone acetate", 
                "Dexamethasone 21-phosphate", 
                "Leucovorin", 
                "Levoleucovorin"
            ]
        }, 
        "keyword": [
            "Vincristine", 
            "Lymphoma", 
            "Methotrexate", 
            "Cyclophosphamide", 
            "Cytarabine", 
            "Dexamethasone", 
            "Doxorubicin", 
            "Drug Therapy, Combination", 
            "Combined Modality Therapy", 
            "Acquired Immunodeficiency Syndrome", 
            "Antineoplastic Agents, Combined", 
            "Zidovudine", 
            "Bleomycin"
        ], 
        "lastchanged_date": "March 28, 2012", 
        "link": {
            "description": "Click here for more information about Zidovudine", 
            "url": "http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=4"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA CARE Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Los Angeles County - USC Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "941102859"
                    }, 
                    "name": "San Francisco AIDS Clinic / San Francisco Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Charity Hosp / Tulane Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Louisiana State Univ Med Ctr / Tulane Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Tulane Univ School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }, 
                    "name": "Univ of Massachusetts Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "Bellevue Hosp / New York Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10025"
                    }, 
                    "name": "Saint Luke's - Roosevelt Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Univ of Rochester Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hershey", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "170330850"
                    }, 
                    "name": "Milton S Hershey Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Columbia", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29169"
                    }, 
                    "name": "Julio Arroyo"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members", 
        "overall_official": {
            "last_name": "Levine A", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "7690462", 
                "citation": "Saag MS, Emini EA, Laskin OL, Douglas J, Lapidus WI, Schleif WA, Whitley RJ, Hildebrand C, Byrnes VW, Kappes JC, et al. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 7;329(15):1065-72."
            }, 
            {
                "PMID": "1710673", 
                "citation": "Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, Bennett JM, Rarick MU, Walsh C, Kahn J, et al. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA. 1991 Jul 3;266(1):84-8."
            }, 
            {
                "citation": "ICDB/89653727. Levine AM, et al. Low dose chemotherapy with CNS prophylaxis and zidovudine (AZT) maintenance for aids-related lymphoma: preliminary results of a multi-institutional study. Proc Annu Meet Am Soc Clin Oncol. 1989 8:A18"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000703"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Bellevue Hosp / New York Univ Med Ctr": "40.714 -74.006", 
        "Charity Hosp / Tulane Univ Med School": "29.951 -90.072", 
        "George Washington Univ Med Ctr": "38.895 -77.036", 
        "Julio Arroyo": "33.993 -81.074", 
        "Los Angeles County - USC Med Ctr": "34.052 -118.244", 
        "Louisiana State Univ Med Ctr / Tulane Med School": "29.951 -90.072", 
        "Milton S Hershey Med Ctr": "40.286 -76.65", 
        "Mount Sinai Med Ctr": "40.714 -74.006", 
        "Saint Luke's - Roosevelt Hosp Ctr": "40.714 -74.006", 
        "San Francisco AIDS Clinic / San Francisco Gen Hosp": "37.775 -122.419", 
        "Tulane Univ School of Medicine": "29.951 -90.072", 
        "UCLA CARE Ctr": "34.052 -118.244", 
        "Univ of Massachusetts Med Ctr": "42.263 -71.802", 
        "Univ of Rochester Medical Center": "43.161 -77.611"
    }
}